Aug 5, 2022 | Featured, Health Policy
WASHINGTON — Patients Rising NOW today released “What You Don’t Know About the Reconciliation Bill,” the organization’s fact-check of the drug pricing provisions within the Senate’s reconciliation bill, or the 725-page Inflation Reduction Act of 2022. The list...
Read more
Jul 25, 2022 | Featured, Health Policy
By Surabhi Dangi-Garimella, PhD Injectable drugs, which are usually manufactured as single-dose vials, are administered by health care providers based on a person’s body weight. Variability in body weight means there is medication left over in the vial, which has to...
Read more
May 13, 2022 | Featured, Health Policy
Surabhi Dangi-Garimella, Ph.D. Despite biosimilars being around for a while, utilization in the U.S. has not caught on. Several studies have shown the cost benefit of replacing originator or reference products with biosimilars; however, contracts between drug...
Read more
Mar 21, 2022 | Featured, Health Policy
On this episode of the podcast, Terry and Bob discuss the healthcare bills Congress is currently considering and what they mean for patients. They break down the D.C. lingo and highlight three healthcare bills that will shape access to care and elevate patient voices:...
Read more
Feb 14, 2022 | Featured, Health Insurance, Health Policy
Season 3 | Episode 6: Making Sense of California’s Healthcare News On this episode of the podcast, Terry and Bob discuss the bid for universal healthcare in California. They also talk about the latest health policy developments at the federal level, including...
Read more
Jan 31, 2022 | Federal Issues, Health Policy
By Surabhi Dangi-Garimella, Ph.D. Repair restrictions by equipment manufacturers remains a significant issue that spans industries and is relevant to consumer protection and antitrust issues related to repair restrictions—be it phone or car manufacturers or...
Read more
